TAVIU · As filed with the SEC
Tavia Acquisition balance sheet, by quarter
The statement as Tavia Acquisition presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Balance Sheets · USD
| USD | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash | — | — | — | — | — | 913,659 |
| Cash | — | — | — | 358,097 | — | — |
| Cash and cash equivalents | — | 344,032 | 229,625 | — | — | — |
| Cash and cash equivalents | 213,484 | — | — | — | 471,826 | — |
| Prepaid expenses | 90,017 | 143,132 | 131,850 | 131,376 | 117,029 | 44,059 |
| Total current assets | 303,501 | 487,164 | 361,475 | 489,473 | 588,855 | 957,718 |
| Marketable securities held in Trust Account | 46,369,473 | 121,816,078 | 120,754,293 | 119,600,533 | 118,363,928 | 115,926,937 |
| Total Assets | 46,672,974 | 122,303,242 | 121,115,768 | 120,090,006 | 118,952,783 | 116,884,655 |
| Current liabilities | ||||||
| Accrued offering costs | — | — | — | 75,000 | 75,000 | 85,000 |
| Accrued offering costs | — | — | 75,000 | — | — | — |
| Accrued expenses | 1,943,667 | 848,921 | 708,156 | 655,062 | 530,445 | 72,448 |
| Related Party | 131,684 | 131,684 | 131,684 | 131,684 | 131,684 | 131,684 |
| Related Party | 860,000 | 800,000 | 500,000 | 500,000 | 500,000 | 500,000 |
| Total Liabilities | 2,935,351 | 1,780,605 | 1,414,840 | 1,361,746 | 1,237,129 | 789,132 |
| Ordinary shares subject to possible redemption, 11,500,000 shares at redemption value of $10.06 per share | — | — | — | — | — | 115,685,866 |
| Ordinary shares subject to possible redemption, 4,332,775 and 11,500,000 shares at redemption value of approximately $10.70 and $10.50 per share as of June 30, 2026 and December 31, 2025, respectively | 46,369,473 | 121,816,078 | 120,754,293 | 119,600,533 | 118,363,928 | — |
| Shareholders’ Deficit | ||||||
| Ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 4,420,833 shares issued and outstanding (excluding 4,332,775 and 11,500,000 subject to possible redemption as of June 30, 2026 and December 31, 2025, respectively) as of June 30, 2026 and December 31, 2025 | 442 | 442 | 442 | 442 | 442 | 442 |
| Additional paid-in capital | — | — | — | — | — | 329,697 |
| Accumulated deficit | (2,632,292) | (1,293,883) | (1,053,807) | (872,715) | (648,716) | 79,518 |
| Total Shareholders’ Deficit | (2,631,850) | (1,293,441) | (1,053,365) | (872,273) | (648,274) | 409,657 |
| Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | 46,672,974 | 122,303,242 | 121,115,768 | 120,090,006 | 118,952,783 | 116,884,655 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.